← Leaderboards
Kandy T Velazquez
University Of South Carolina At Columbia
$2,636,909
Attributed
$2,902,217
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $729.1K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,196,221 · 7
By mechanism
R01$1,051,908 · 1
R00$747,000 · 1
P20$472,623 · 2
R21$373,830 · 1
R43$351,998 · 1
K99$198,862 · 1
Top collaborators
- Brandon Vanderveen2 shared
- Reilly Enos1 shared
- Mitzi Nagarkatti1 shared
- Prakash S. Nagarkatti1 shared
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Gloria S McCutcheon$2,038,908
- Bridgette Lynne Kelleher$5,393,793
- Deborah M. Parra-Medina$14,875,407
- Reilly Enos$859,231
- Xiaoming Li$23,837,537
Others in their field
Other Emerging Leaders on “Inflammation”
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Jacob D Estes · Oregon Health & Science University$13,447,606
- Bradley G Hammill · Duke University$13,296,940
- James Dale Berry · Brigham And Women'S Hospital$11,004,714
- Gary Fanger · Rise Therapeutics, Llc$10,261,718
- Barbara Halina Braffett · George Washington University$9,972,097
Research focus
InflammationLinkMalignant NeoplasmsAutomobile DrivingPreventPlayAnti-Inflammatory AgentsEffective TherapyCancer PatientPropertyQuality Of LifeMacrophageCancer TherapyCachexiaMuscle FormMediatingMuscular AtrophyDoseMuscleBody Weight DecreasedCancer CachexiaChronicMuscle FunctionSkeletal Muscle
Grant awards (13)
The Role of TGFβ2 and Macrophages in Cancer Cachexia$527,199
R01 · FY2025 · CA · contact PI
The Role of Platelets in Cancer Cachexia$169,439
R21 · FY2025 · CA · contact PI
The Role of TGFβ2 and Macrophages in Cancer Cachexia$524,709
R01 · FY2024 · CA · contact PI
The Role of Platelets in Cancer Cachexia$204,391
R21 · FY2024 · CA · contact PI
Dietary Supplements and Inflammation Phase-2: Isoxanthohumol as a treatment for estrogen-deficient-induced visceral hyperalgesia.$294,004
P20 · FY2023 · GM
Silybin as an anti-inflammatory and anti-fibrotic agent in cancer cachexia$178,619
P20 · FY2022 · GM · contact PI
The effects of Ojeok-san on neuro-immune interactions in cancer-induced visceral pain$249,000
R00 · FY2021 · AT · contact PI
Development of Dietary Quercetin to Treat Muscle Wasting Disorders$52,000
R43 · FY2021 · AT
Development of Dietary Quercetin to Treat Muscle Wasting Disorders$299,998
R43 · FY2020 · AT
The effects of Ojeok-san on neuro-immune interactions in cancer-induced visceral pain$249,000
R00 · FY2020 · AT · contact PI
The effects of Ojeok-san on neuro-immune interactions in cancer-induced visceral pain$249,000
R00 · FY2019 · AT · contact PI
The effects of Ojeok-san on neuro-immune interactions in cancer-induced visceral pain$92,214
K99 · FY2018 · AT · contact PI
The effects of Ojeok-san on neuro-immune interactions in cancer-induced visceral pain$106,648
K99 · FY2017 · AT · contact PI